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Introduction: In every case of upper gastrointestinal bleeding suspicion, an
endoscopic examination ought to be performed as a matter of urgency. Finding
active bleeding, a visible non-bleeding vessel or a lesion with an adherent clot
should be followed by application of an available method of endoscopic therapy.
The aim of the study was to compare the effectiveness of various endoscopic
treatment techniques such as epinephrine injections, coagulation methods and
mechanical methods in the treatment of non-varicose upper gastrointestinal
bleeding.
Material and methods: Sixty cases of non-varicose upper gastrointestinal
bleeding were analysed in terms of the effectiveness of the above-mentioned
procedures used in monotherapy or in combination therapy comprising
epinephrine injections and clips application. The choice of the applied procedure
depended on morphological features and location of the bleeding source, the
patient’s general condition, as well as technical equipment and manual skills of
the endoscopy staff.
Results: The study confirmed the effectiveness of endoscopic treatment of non-
varicose upper gastrointestinal bleeding applying the above-mentioned methods.
In most patients, this treatment enabled traumatic surgical intervention to be
avoided; it was required in only 3 (5%) out of 60 patients with confirmed upper
gastrointestinal bleeding. With the first endoscopy, haemostasis was achieved
in 47 cases (78.3%) and the second endoscopy, performed due to bleeding
recurrence, was successful in the remaining 10 cases (16.7%). 
Conclusions: In non-varicose upper gastrointestinal bleeding, urgent diagnostic
and therapeutic endoscopy should be the first-line management. If the lesion
that is the source of bleeding is possible to localize, the endoscopic techniques
should be applied. Among the endoscopic procedures used in monotherapy,
clips appeared to be the most effective, their effectiveness being comparable
to combination therapy. In bleeding from extensive lesions, coagulation methods
are considered to be the most efficacious.
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Introduction
Acute gastrointestinal bleeding is the most
common life-threatening condition in ga  stroente  -
rology. Upper gastrointestinal bleeding comprises
90% of cases of gastrointestinal bleeding and
constitutes an important medical problem all over
the world. Its incidence has been estimated at 
30 to 150 cases per 100 000 inhabitants. The
incidence of upper gastrointestinal bleeding
increases with age and over the age of 75 reaches
400 per 100 000 people of this population [1, 2].
The most common sources of non-varicose
upper gastrointestinal bleeding are: gastric and
duodenal ulcers (56%), erosions (10%), oesophagitis
(9%), Dieulafoy lesions (2%), gastric neoplasms
(4%), and Mallory-Weiss tears (4%) [3]. Among the
factors damaging gastric mucous membrane,
Helicobacter pylori infection should be mentioned
as well as non-steroid anti-inflammatory drugs,
especially salicylates, pyrazolones and arylacetate
derivatives [4]. In recent years, the frequency of
upper gastrointestinal bleeding caused by the
intake of antiplatelet drugs other than acetylsalicylic
acid (ticlopidine, clopidogrel), as well as selective
serotonin reuptake inhibitors (SSRI), has been
increasing. Mortality due to this disease remains at
the level of 7-14%. In patients with concomitant
severe diseases and in the case of bleeding
recurrence the mortality even exceeds 40% [5].
Eighty percent of all cases of upper gastrointestinal
bleeding end spontaneously, while in the remaining
20% of cases, untreated bleeding may lead to
patients’ death [6]. In 80% of these patients proper
endoscopic treatment results in bleeding arrest. In
the remaining 20% of patients, despite the
previously achieved effective haemostasis, the lack
of appropriate treatment leads to bleeding
recurrence. 
Complying with the proper algorithm of ma  -
nagement should be obligatory in every case 
of non-varicose upper gastrointestinal bleeding
(Figure 1) [5].
Despite the application of endoscopic therapy,
several percent of patients may require surgical
intervention. Patients with the following sym  ptoms
are considered as candidates for such treatment:
• massive bleeding, which is difficult to control,
• subsequent recurrence of bleeding after attempts
of endoscopic and pharmacological therapy,
• the source of massive bleeding is situated on the
posterior wall of the duodenal bulb.
Endoscopic examination in patients with acute
non-varicose upper gastrointestinal bleeding should
be performed as soon as possible after admission
to hospital and should be carried out in
haemodynamically stable patients. Endoscopy
allows one not only to localize the source of
bleeding and to apply local treatment but also to
gain information essential for the proper




followed by its continuous infusion
High risk features:
   • active bleeding
   • visible non-bleeding vessel
Endoscopic therapy




   • adherent clot
   • flat, colourful spot in ulcer bed
   • clean ulcer bed
Figure 1. Algorithm of management of non-varicose upper gastrointestinal bleeding [5] 
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prognosis. During endoscopic examination, the
following various therapeutic options may be
applied individually or together:
• injections of epinephrine, tissue adhesives or
thrombin,
• thermal methods, such as thermal probe, argon
plasma coagulation (APC) or laser photo  -
coagulation,
• mechanical methods, such as haemostatic clips
or elastic bands.
Material and methods
In the study, we compared the effectiveness of
the following various endoscopic methods of
treating non-varicose upper gastrointestinal
bleeding:
1) injections of 1 : 10 000 solution of epinephrine
(in normal saline),
2) application of haemostatic clips,
3) electrocoagulation,
4) APC.
The above-mentioned methods were applied as
monotherapy or combination therapy, combining
injections and clips application.
Sixty cases of upper gastrointestinal bleeding
that underwent endoscopic therapy in 2006 were
analysed. Patients were either admitted to hospital
due to suspicion of upper gastrointestinal bleeding
or, in 10 cases, the upper gastrointestinal bleeding
occurred during hospitalization due to other
reasons, mainly in surgery departments. The
numbers of patients from respective departments
were as follows: neurosurgery – 4, orthopaedic
surgery – 3, intensive care unit – 2, department of
internal medicine – 1.
The endoscopic treatment was performed at the
Medical University of Lodz, in the Gastrointestinal
Endoscopy Laboratory of University Hospital No. 2,
in accordance with Figure 1. The only modification
concerned the cases with adherent clot (Forrest IIb)
that were qualified for endoscopic therapy only
after previously removing the clot. The time
between upper gastrointestinal bleeding suspicion
and the beginning of endoscopic examination did
not exceed 3 h and in most cases it was shorter
than 1 h. Prokinetics were not administered before
the endoscopy. All patients were given proton pump
inhibitor (PPI). The study group consisted of 60 pa  -
tients, including 52 men and 8 women aged
between 31 years and 84 years. The patients were
assigned to the group due to the following
symptoms: tarry stool, haematemesis or coffee-
ground vomiting combined with unexplained
decrease in values of red blood cell parameters or
haemodynamic instability (tachycardia, blood
pressure lowering). The patients in whom upper
gastrointestinal bleeding was not confirmed, or
surgical endoscopic procedures were not
performed, or oesophageal varices were diagnosed
as the source of bleeding, were not included in the
study group. The patients classified as Forrest Ia,
Ib, IIa and IIb were qualified for endoscopic therapy.
The method of endoscopic treatment was chosen
for each patient according to the type of lesion that
was the source of bleeding, its location and
technical possibility of performing the endoscopic
procedure. 
Results
Our study revealed that duodenal or gastric ulcers
were the most common sources of bleeding,
constituting 48% and 33%, respectively. Less
frequently the bleeding occurred due to Mallory-
Weiss syndrome (7%), neoplasms (7%) or other
reasons (5%). In the study, the number of patients
cured after the first and the second endoscopic
therapy was 47 and 10, respectively. Despite a double
attempt of endoscopic treatment, 3 patients had to
undergo surgical intervention (Table I). 
In most patients with duodenal or gastric ulcers
application of the injection method or clips was
successful during the first endoscopy. However, in
some cases a second endoscopy (duodenal and
gastric ulcers – 4 and 2 patients, respectively) or
surgical intervention (2 patients with duodenal
ulcers) was required due to bleeding recurrence. All
Cause of bleedingN umber  Proportion Cured after Cured  after Surgical
of cases of cases [%] the 1st endoscopy the  2nd endoscopy intervention
Duodenal ulcer 29 48 22 5 2
Gastric ulcer 20 33 16 4 0
Mallory-Weiss syndrome 4 7 4 0 0
Neoplasms 4 7 2 1 1
Vascular malformations 2 3.5 2 0 0
Dieulafoy lesions 1 1.5 1 0 0
Total 60 100 47 (78%) 10 (17%) 3 (5%)
Table I. The relationship between the causes of upper gastrointestinal bleeding and the outcome of endoscopic
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4 patients with Mallory-Weiss syndrome as well as
the only patient with Dieulafoy lesion were cured
after the first attempt of clips application (Table II). 
Combination therapy, combining injections and
clips application, was highly effective in patients
with duodenal or gastric ulcers, and only 1 out of 
7 patients needed a second endoscopic therapy
because of bleeding relapse (Table II).
In the study, electrocoagulation was applied in
some cases of gastric ulcer and neoplastic lesion,
but most patients (2 out of 3) were cured only after
the second endoscopy (Table II).
The endoscopic therapy based on APC allowed
most patients to be cured during the first endoscopy.
Only in 1 patient, in whom gastric ulcer was the
source of bleeding, was a second attempt of
endoscopic treatment required to achieve complete
haemostasis, and another one had to undergo
surgical intervention, but in this case a neoplastic
lesion was the source of bleeding (Table II).
The patients were monitored during a 30-day
follow-up from the first bleeding occurrence. In this
period of time, none of the case observations ended
in death.
Discussion
Endoscopic treatment of non-varicose upper
gastrointestinal bleeding gives patients the
opportunity to avoid traumatic surgical inter  -
ventions, and allows the percentage of bleeding
recurrence and the number of deaths to be reduced.
In our study group, only 5% of patients had to
undergo surgical intervention, in 17% of cases
a second endoscopy was required due to bleeding
recurrence, whilst as many as 78% were cured by
a single endoscopy. Our results are consistent with
other research outcomes [7, 8]. The choice of the
endoscopic treatment method was based on
endoscopist skills and experience, technical
equipment available as well as the type and location
of the bleeding lesion.
In our study we have confirmed that epinephrine
injection therapy allows one to achieve early
haemostasis in almost all patients but the risk 
of bleeding recurrence reaches the level of 15-20%
[9, 10]. Although haemostasis was achieved in all of
our 17 patients in whom this method was applied,
5 (29%) of them developed recurrence of bleeding.
The application of this method is limited by the
lesion size and the lack of visible bleeding source.
The bigger the area of mucous membrane damage,
the more difficult it is to use the injection method. 
The application of haemostatic clips was the
mechanical method chosen in our study group. The
literature data suggest that this kind of treatment
is useful in every type of lesion if the vessel that is
the bleeding source is visible [11-13]. Our experience
indicates that the surroundings of the damaged
vessel and its location are of great importance in
applying this method. In our study, in a few cases
we were unable to apply clips due to a tough base
or difficult location of the lesion (the posterior wall
of the duodenal bulb, the posterior wall and the
small curvature of the stomach). Despite the above-
mentioned difficulties, this method appeared to be
the most effective in our study. Only 1 in 15 cases
required a second endoscopy, which was performed
successfully. Our observations suggest that no more
than 1-3 clips should be applied. Every attempt of
the next clips application ended in failure or led to
changes in the position of the clips previously
applied [14, 15]. 
Coagulation methods such as electrocoagulation
and APC allow one to achieve haemostasis by
coagulation of the bleeding vessel and the
surrounding tissues. In our laboratory we apply
Cause Method
Injections Clips Electrocoagulation APCI n jections 
+ clips
E1 E2 S E1 E2 S E1 E2 S E1 E2 S E1 E2 S
Duodenal ulcer 11 3 2 5 1 0 0 0 0 0 0 0 6 1 0
Gastric ulcer 6 2 0 4 0 0 1 1 0 1 1 0 4 0 0
Mallory-Weiss 
syndrome 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0
Neoplasms 0 0 0 0 0 0 0 1 0 2 0 1 0 0 0
Vascular 
malformations 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0
Dieulafoy 
lesions 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
Table II. The relationship between the methods applied and the treatment outcome depending on the bleeding cause
E1 – number of patients cured after the first endoscopy, E2 – number of patients cured after the second endoscopy, 
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these methods in stopping ulcer bleeding if there
is no possibility of using the injection method or
clips application (lesion size, tough base) or for
bleeding from neoplastic lesions or vascular
malformations. Electrocoagulation has been found
effective in gastric ulcers and neoplastic lesions;
however, in most cases complete haemostasis was
achieved only after the second endoscopy
performed 24 h after the first one. The effectiveness
of both electrocoagulation and APC is comparable
to the injection method [16-18], which was
confirmed in our study. 
The superiority of combination therapy,
comprising the injection method and other
techniques, to every type of endoscopic mono  -
therapy is emphasized in the literature [8, 19-22].
In our study, the effectiveness of the injection
method combined with the mechanical method
(clips) has been evaluated. Only in 1 out of 11 cases
of gastric or duodenal ulcer bleeding did its
recurrence occur and it was treated with another
epinephrine injection and clips application. In this
case, the presence of the previously applied two
clips was not confirmed during the second
endoscopy. Premature spontaneous evacuation of
the clips (before 48 h) was the most probable cause
of the bleeding recurrence. 
In each case of bleeding relapse, a second attempt
of endoscopic therapy was made. In the case of
failure of this second effort of endoscopic treatment,
the patient underwent surgical intervention. In our
study, among 60 cases treated, bleeding recurrence
occurred in 10 patients (17%) and in 3 of them (30%)
surgical intervention was needed. Our results are
consistent with the observations of other authors,
who emphasize the fact that 25–50% of patients
with bleeding relapse after endoscopic treatment
require surgical intervention [23].
In conclusion, in the case of upper gas  -
trointestinal bleeding, endoscopy should be the
most important element of the diagnostic and
therapeutic process. In such situations, the
endoscopic examination should be performed as
a matter of urgency, after the previous correction
of haemodynamic disorders. When the source of
bleeding can be found and classified as Forrest Ia,
Ib, IIa or IIb, the attempt of endoscopic therapy
should be made. In the case of bleeding recurrence
after the first effective treatment, a second attempt
of endoscopy ought to be made. Failure to achieve
haemostasis and/or severe patient condition
making the endoscopy impossible are indications
for urgent surgical intervention. The choice of
endoscopic treatment method depends on the type
of lesion that is the source of bleeding, its
morphological features and location, technical
equipment and manual skills of the endoscopy staff
as well as the patient’s general condition. In small
lesions with a clearly visible bleeding vessel, the
mechanical method of applying 1-3 clips is the most
effective treatment. In the case of extensive lesions
where the bleeding vessel is impossible to find, e.g.
a tumour mass, coagulation techniques are
considered as the first-line treatment. 
Although combination therapy, including
epinephrine injections and clips, seems to be more
effective than monotherapy based on either of
these methods, our study revealed that the
effectiveness of clips application is comparable to
the combination treatment.
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